Advertisement
News
Advertisement

Device makers release a flurry of studies at European conference

Wed, 05/26/2010 - 11:38am
Mass Device

Most of the major players in the medical device arena, and a few from off the bench, are busy touting new products and results from a slew of clinical trials at the European Assn. of Percutaneous Cardiovascular Interventions annual conference, EuroPCR 2010:

Abbott (NYSE:ABT):

Abiomed Inc. (NSDQ:ABMD):

  • Abiomed Reports Updated USpella Results Presented at EuroPCR 2010:

    52% of patients improved New York Heart Association (NYHA) classification by one or more categories after Impella-supported complex PCI. Prior to treatment, 63% of patients were in NYHA class three or four. After treatment, 70% were in NYHA class one or two.

Cordis Corp. [Johnson & Johnson (NYSE:JNJ)]:

InspireMD Ltd.:

Medtronic Inc. (NYSE:MDT):

NMT Medical Inc. (NSDQ:NMTI):

NovoStent Corp.:

OrbusNeich:

St. Jude Medical Inc. (NYSE:STJ):

Tryton Medical Inc.:

SOURCE

Topics

Advertisement

Share this Story

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading